Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
R. Nicolle, Y. Blum, P. Duconseil, C. Vanbrugghe, N. Brandone, F. Poizat, J. Roques, M. Bigonnet, O. Gayet, M. Rubis, N. Elarouci, L. Armenoult, M. Ayadi, A. Dereynies, M. Giovannini, , N. J. Dusetti
This paper develops a transcriptomic gradient (PAMG) to predict pancreatic cancer aggressiveness and treatment response using patient-derived xenografts and clinical data.
bioRxiv · Mar 25, 2020Cancer Biology